China's 2021 Medical Product Sales Exceed $360B

by Grace Wang Sep 28, 2022

According to the Statistical Report on Pharmaceutical Circulation Industry issued by China's Ministry of Commerce on Sept. 6, the national sales of medical products in 2021 reached 2,606.4 billion yuan (367.71 billion USD), with a year-on-year (YoY) growth of 8.5%.1

China's Medical Product Sales from 2017 to 2021China's Medical Product Sales from 2017 to 2021 [Data source: Ministry of Commerce]

Market Segmentation by Product Category

Among the sales of medical products, Western drugs (including chemical drugs and biological products) accounted for the highest share, followed by finished traditional Chinese medicines (TCMs) and TCM ingredients. These three combined categories amounted to 87.7% of the total sales.

As for the rest of shares, 7.8% belonged to medical devices, 0.7% to chemical reagents, less than 0.1% to glassware, and 3.8% to other medical products.

Market Shares of China's Medical Products in 2021Market Shares of China's Medical Products in 2021 [Data Source: Ministry of Commerce]

Market Shares by Buyers

99.8% medical products were bought by Chinese companies and customers while only 0.2% were directly sold to overseas buyers.

Among the products sold in China, 51.01% were procured by medical institutions, followed by 27.3% purchased by wholesalers, and 20.99% by retailers and individual customers. Products sold to manufacturers accounted for less than 1%.

Buyer

Purchase amount (bln yuan)

Market share

Chinese   buyers

A. Medical institutions (hospitals, healthcare centers, etc.)

1,329.6

51.01%

B. Wholesalers

713

27.3%

C.  Retailers and individual customers

547.1

20.99%

D. Manufacturers

12.6

0.5%

E. (Directly exported to) overseas buyers

4.1

0.2%

Data source: Ministry of Commerce

From 2017 to 2021, drugs sold to Chinese manufacturers / overseas buyers maintained at a share lower than 5%. In contrast, drugs sold to medical institutions remained at a high level of over 40%. Due to the volume-based procurements (VBPs) since 2018, medical institutions are expected to continue taking up the highest purchase share.

The wholesalers' purchase share dropped while retailers and individual customers' share slightly rose. Moreover, the retail channels, especially online drugstores, are predicted to grow fast with online sale to be permitted for prescription drugs from Dec. 1, 2022.

China Medical Product Market Shares by Buyers from 2017 to 2021China Medical Product Market Shares by Buyers from 2017 to 2021 [Data Source: Ministry of Commerce]

Grace Wang
ChemLinked Regulatory Analyst & Editor
+ FOLLOW
Copyright: unless otherwise stated all contents of this website are ©2024 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com
You May Also Like
Most Popular